Cooper, L. B., Lippmann, S. J., Greiner, M. A., Kelly, J. P., Sharma, A., Fonarow, G. C., … Hernandez, A. F. (2016). Mineralocorticoid Receptor Antagonist Use in Patients With Heart Failure and Co-Morbid Diabetes or Chronic Kidney Disease. In CIRCULATION (Vol. 134). Pentagon City, VA: LIPPINCOTT WILLIAMS & WILKINS.

Cooper, Lauren B., Steven J. Lippmann, Melissa A. Greiner, Jacob P. Kelly, Abhinav Sharma, Gregg C. Fonarow, Clyde W. Yancy, Paul A. Heidenreich, and Adrian F. Hernandez. “Mineralocorticoid Receptor Antagonist Use in Patients With Heart Failure and Co-Morbid Diabetes or Chronic Kidney Disease.” In CIRCULATION, Vol. 134. LIPPINCOTT WILLIAMS & WILKINS, 2016.

Cooper LB, Lippmann SJ, Greiner MA, Kelly JP, Sharma A, Fonarow GC, et al. Mineralocorticoid Receptor Antagonist Use in Patients With Heart Failure and Co-Morbid Diabetes or Chronic Kidney Disease. In: CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2016.

Cooper, Lauren B., et al. “Mineralocorticoid Receptor Antagonist Use in Patients With Heart Failure and Co-Morbid Diabetes or Chronic Kidney Disease.” CIRCULATION, vol. 134, LIPPINCOTT WILLIAMS & WILKINS, 2016.

Cooper LB, Lippmann SJ, Greiner MA, Kelly JP, Sharma A, Fonarow GC, Yancy CW, Heidenreich PA, Hernandez AF. Mineralocorticoid Receptor Antagonist Use in Patients With Heart Failure and Co-Morbid Diabetes or Chronic Kidney Disease. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2016.